Showing results (141-150 of 169) with videos related to
Sort By:
Pageof 17
Molecular Cell|May 1, 2018
HMGB2 Loss upon Senescence Entry Disrupts Genomic Organization and Induces CTCF Clustering across Cell TypesAnne Zirkel, Milos Nikolic, Konstantinos Sofiadis, et al.Molecular Oncology|November 19, 2019
Expression of CCCTC-binding factor (CTCF) is linked to poor prognosis in prostate cancerDoris Höflmayer, Amélie Steinhoff, Claudia Hube-Magg, et al.The Prostate|November 16, 2018
Loss of CCAAT-enhancer-binding protein alpha (CEBPA) is linked to poor prognosis in PTEN deleted and TMPRSS2:ERG fusion type prostate cancersSarah Minner, Jannes Lutz, Claudia Hube-Magg, et al.Cancers|March 10, 2022
PITX1 Is a Regulator of TERT Expression in Prostate Cancer with Prognostic PowerAlexandra M Poos, Cornelia Schroeder, Neeraja Jaishankar, et al.Blood|June 30, 2023
Resolving therapy resistance mechanisms in multiple myeloma by multiomics subclone analysisAlexandra M Poos, Nina Prokoph, Moritz J Przybilla, et al.Immunity|December 8, 2021
Interleukin-10 receptor signaling promotes the maintenance of a PD-1int TCF-1+ CD8+ T cell population that sustains anti-tumor immunityBola S Hanna, Laura Llaó-Cid, Murat Iskar, et al.Plos Genetics|April 18, 2013
Epigenetic upregulation of lncRNAs at 13q14.3 in leukemia is linked to the In Cis downregulation of a gene cluster that targets NF-kBAngela Garding, Nupur Bhattacharya, Rainer Claus, et al.Nature Communications|July 16, 2026
Multiomic profiling links L1 retrotransposition to genomic instability and ecDNA in bladder cancerSophia J Pribus, Ivana Osredek, Jan Otoničar, et al.Nature Cell Biology|June 17, 2020
Dissecting intratumour heterogeneity of nodal B-cell lymphomas at the transcriptional, genetic and drug-response levelsTobias Roider, Julian Seufert, Alexey Uvarovskii, et al.JHEP Reports : Innovation in Hepatology|October 27, 2021
Control of APOBEC3B induction and cccDNA decay by NF-κB and miR-138-5pSuzanne Faure-Dupuy, Tobias Riedl, Maude Rolland, et al.Pageof 17